Financial Performance - The company reported a decline in foreign sales revenue due to weak demand in overseas markets, contributing to overall performance losses [3]. - The company's operating revenue for 2023 was ¥259,857,941.97, an increase of 7.04% compared to ¥242,773,752.42 in 2022 [25]. - The net profit attributable to shareholders was -¥23,874,906.99, a decrease of 6.07% from -¥22,509,546.17 in the previous year [25]. - The net cash flow from operating activities decreased by 55.28% to ¥20,144,239.74 from ¥45,043,936.75 in 2022 [25]. - The total assets at the end of 2023 were ¥852,355,845.49, reflecting a 6.63% increase from ¥799,363,305.72 at the end of 2022 [25]. - The basic earnings per share for 2023 was -¥0.16, a decline of 6.67% compared to -¥0.15 in 2022 [25]. - The company reported a quarterly revenue of ¥80,175,325.94 in Q4 2023, which is the highest among the four quarters [27]. - The net profit attributable to shareholders in Q4 2023 was -¥6,828,738.94, showing a significant loss [28]. - The company’s net assets attributable to shareholders decreased by 3.70% to ¥621,401,645.53 at the end of 2023 from ¥645,276,552.52 at the end of 2022 [25]. - The company experienced a total of ¥8,919,099.54 in non-recurring gains and losses for 2023 [32]. Market and Industry Trends - The company operates in the plastic packaging industry, which has shown signs of recovery post-pandemic, particularly in the Asia-Pacific region [36]. - The retail sales of cosmetics in China increased from CNY 134.01 billion in 2012 to CNY 402.6 billion in 2021, with a compound annual growth rate (CAGR) of 11.63% [37]. - In 2022, the retail sales of cosmetics in China were CNY 393.6 billion, a decrease of 2.24% compared to 2021, but in 2023, it rebounded to CNY 414.2 billion, reflecting a year-on-year growth of 5.23% [37]. - The Asia-Pacific region is currently the largest cosmetics consumption market globally, with China, Japan, India, Brazil, and the United States projected to be the top five demand markets by 2025 [37]. - The cosmetic plastic packaging industry is less affected by economic cycles, with stable consumer demand due to the diversification of cosmetic brands and the expanding consumer base [40]. Product Development and R&D - The company plans to enhance R&D investment to improve product quality and develop new products, aiming to strengthen market competitiveness [4]. - The company has developed a strong R&D capability, holding 72 patents and mastering core technologies in mold development, design, manufacturing, and injection molding [62]. - The company has completed several new product developments, including a new structure series for packaging that enhances design efficiency and reduces costs [84]. - The company is focused on developing new products in the color cosmetics and personal care sectors to extend its product offerings and enhance its market position [117]. - The company is investing in R&D, with a budget increase of 10% to enhance product innovation and technology development [185]. Operational Efficiency and Cost Management - The production capacity utilization rate for the new project of 45 million cosmetic packaging containers did not significantly improve, leading to higher fixed costs [3]. - The company is committed to optimizing business processes and enhancing internal control management to improve overall operational profitability [4]. - The company has implemented a production model based on sales orders, ensuring efficient order delivery and maintaining low inventory levels [53]. - The company aims to reduce operational costs by 5% through efficiency improvements in the supply chain [185]. - The company is focused on improving production efficiency and strengthening information management across procurement, production, inventory, and sales [190]. Financial Management and Governance - The company will not distribute cash dividends, issue bonus shares, or increase capital using reserves, indicating a focus on reinvestment [7]. - The company has established an independent financial management system and does not share bank accounts with its controlling shareholder [135]. - The company has a governance structure with a board term set from November 2022 to November 2025 for several key executives [138]. - The company has maintained a stable shareholding structure with no significant changes reported in the current period [138]. - The company reported a total compensation of RMB 4.8474 million for directors, supervisors, and senior management during the reporting period [150]. Shareholder Relations and Compliance - The company emphasizes the protection of the interests of all shareholders, particularly minority investors [157]. - The company is committed to transparency and compliance with relevant laws and regulations regarding its IPO and share transactions [184]. - The company will announce any share reduction plans three trading days in advance and complete the reduction within six months [187]. - The company will ensure that the share reduction price does not fall below the IPO price or the latest net asset value per share [187]. - The company will publicly explain any failure to fulfill commitments and apologize to shareholders and investors [189]. Environmental Responsibility - The company has implemented energy-saving measures, including the use of photovoltaic low-voltage distribution cabinets and solar panels, to reduce carbon emissions [176]. - All waste produced during the manufacturing process has been effectively disposed of, complying with relevant environmental regulations [177]. - The company has committed to fulfilling its social responsibility regarding ecological environment protection without any pollution incidents [177]. - The company plans to release its 2023 Social Responsibility Report on April 25, 2024 [178]. Future Outlook and Strategic Initiatives - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% [185]. - Market expansion plans include entering two new international markets by the end of the next fiscal year [185]. - The company is considering strategic acquisitions to enhance its market position, with a budget of 500 million yuan allocated for potential deals [185]. - The company aims to enhance investor confidence and maintain stock price stability through these measures [182].

本人作为浙江锦盛新材料股份有限公司（以下简称"公司"）第三届董事会独立董 事，在 2023 年任职期间，根据《公司法》《证券法》《深圳证券交易所创业板股票上 市规则》等法律法规和规范性文件以及《公司章程》《独立董事工作制度》等规定和 要求，诚实、勤勉、独立地履行职责，认真审议董事会各项议案，切实维护公司股东， 尤其是中小股东的利益，较好地发挥了独立董事作用。现将本人 2023 年度履行独立董 事职责情况汇报如下： 浙江锦盛新材料股份有限公司 一、 基本情况 本人陆培明，硕士研究生学历，高级经济师。2022 年 11 月至今，任公司独立董事； 曾任上海玉石雕刻厂团委书记、上海市二轻局团委负责人、共青团上海市委统战部干 部、城市酒店（上海）董事长 、上海青年实业（集团）有限公司监事长。 独立董事 2023 年度述职报告 （陆培明） 各位股东及股东代表： 二、 2023 年度履职情况 （一） 参加会议情况 2023 年度，公司共召开五次董事会会议，本人均按时出席会议，无缺席或委托其 他独立董事出席会议的情况。本着恪尽职守、诚信客观的原则，本人对董事会上的各 项提案均进行了认真审议，积极参与议案讨论，发表意见，以谨慎 ...

关于开展以套期保值为目的的金融衍生品交易业务的可行性分析报告 一、开展金融衍生品交易业务的目的 为有效控制公司及控股子公司销售商品和采购原材料等日常经营活动中使用外 币结算产生的汇率波动风险，公司及控股子公司拟开展以套期保值为目的的金融衍 生品交易业务，合理利用金融工具锁定成本，降低风险，提高公司竞争力。公司此 次开展金融衍生品交易业务均以正常生产经营为基础，不以投机套利为目的，是为 了规避外汇市场风险，降低汇率及利率波动对公司利润的影响，合理降低财务费用， 不影响公司主营业务的发展。 二、金融衍生品业务基本情况 浙江锦盛新材料股份有限公司 1、 交易品种 本次拟实施的金融衍生品交易业务主要包括远期、期权、互换、期货等产品或 上述产品的组合，对应基础资产包括利率、汇率、货币、商品或上述资产的组合。 2、 交易对手 公司拟开展金融衍生品交易业务的交易对手方为经营稳健、资信良好，具有金 融衍生品交易业务经营资格的银行等金融机构，与公司及控股子公司不存在关联关 系。 3、 投资金额及期限 公司及控股子公司拟开展以套期保值为目的的金融衍生品交易业务，额度合计 不超过等值人民币15,000万元（含前述交易的收益进行再交 ...

浙江锦盛新材料股份有限公司 关于 2023 年度会计师事务所履职情况评估报告 浙江锦盛新材料股份有限公司（以下简称"公司"）聘请中汇会计师事务所 （特殊普通合伙）（以下简称"中汇会计师事务所"、"中汇"）作为公司 2023 年度审计机构。根据财政部、国资委及证监会颁布的《国有企业、上市公司选聘 会计师事务所管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》等要求，公司对中汇会计师事务所 2023 年审计过程中 的履职情况进行评估。经评估，公司认为中汇会计师事务所资质等方面合规有效， 履职保持独立性，勤勉尽责，公允表达意见，具体情况如下： 一、 资质条件 中汇会计师事务所（特殊普通合伙），于 2013 年 12 月转制为特殊普通合伙， 管理总部设立于杭州，系原具有证券、期货业务审计资格的会计师事务所之一， 长期从事证券服务业务。注册地址为浙江省杭州市上城区新业路 8 号华联时代大 厦 A 幢 601 室，执行事务合伙人余强。 截至 2023 年 12 月 31 日，合伙人数量 103 人，注册会计师人数 701 人，签 署过证券服务业务审计报告的注册会计师人数 282 人。 ...

国投证券股份有限公司 关于浙江锦盛新材料股份有限公司 2023年度内部控制自我评价报告的核查意见 国投证券股份有限公司（以下简称"国投证券"、"保荐机构"）作为浙江 锦盛新材料股份有限公司（以下简称"锦盛新材"或"公司"）首次公开发行股 票并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳 证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第2 号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第13 号——保荐业务》等有关规定的要求，针对锦盛新材出具的《2023年度内部控制 自我评价报告》，对锦盛新材2023年度内部控制情况，采取了包括了解、测试和 评价内部控制设计的合理性和执行的有效性，以及认为必要的其他程序，进行了 审慎核查。具体情况如下： 一、公司关于内部控制自我评价的声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其 有效性，并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建 立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运行。公 司董事会、监事会及董事、监事、高级管理人员保证《2023年度内部控制自 ...

证券代码：300849 证券简称：锦盛新材 公告编号：2024-012 浙江锦盛新材料股份有限公司 董事会 2024 年 4 月 25 日 一、 本次向金融机构申请授信额度的情况 为满足公司生产经营和战略实施的需要，保证公司及合并报表范围内的子公 司经营活动中融资业务正常开展，公司及合并报表范围内的子公司拟向银行等金 融机构申请合计不超过人民币 6 亿元（或等值外币）的综合授信额度。该等授信 下的贷款可采用公司及子公司的自有资产进行抵押、质押担保。授信形式包括但 不限于流动资金贷款、开立银行承兑汇票、信用证、保函、办理商业（银行）承 兑汇票贴现、出口保理、贸易融资、项目贷款等。授信形式、授信额度、授信期 限最终以银行等金融机构实际审批的情况为准，上述授信额度不等同于公司实际 发生的融资金额，具体融资金额将根据公司及子公司自身运营的实际需求来合理 确定。该授信额度期限自 2023 年度股东大会审议通过之日起至 2024 年度股东大 会召开日止，授信期限内，授信额度可循环使用。 为办理上述银行等金融机构综合授信额度申请及后续相关借款、担保等事 项，提议股东大会授权公司董事长或其指定的授权代理人负责对外签署在上述综 ...

证券代码：300849 证券简称：锦盛新材 公告编号：2024-011 浙江锦盛新材料股份有限公司 关于公司 2024 年度董事、监事和高级管理人员薪酬方案的 公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江锦盛新材料股份有限公司（以下简称"公司"）于 2024 年 4 月 23 日 召开第三届董事会第七次会议审议通过《关于公司 2024 年度非独立董事薪酬 方案的议案》、《关于公司 2024 年度独立董事薪酬方案的议案》、《关于公 司 2024 年度高级管理人员薪酬方案的议案》；第三届监事会第六次会议审议 《关于公司 2024 年度监事薪酬方案的议案》。具体薪酬方案如下: 一、 适用对象 公司的董事、监事、高级管理人员。 二、 适用期限 2024 年 1 月 1 日至 2024 年 12 月 31 日。 三、 董监高薪酬标准 1、 独立董事：独立董事在公司领取津贴，每人每年 8 万元人民币（含 税），除此之外无其他报酬，独立董事的津贴标准经股东大会审议通过后按季 发放。独立董事因出席公司董事会和股东大会的差旅费及依照《公司章程》行 使职权时所需的其 ...

浙江锦盛新材料股份有限公司董事会审计委员会 对会计师事务所 2023 年度履行监督职责情况报告 浙江锦盛新材料股份有限公司（以下简称"公司"）董事会审计委员会根据 《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等规 定和要求，本着勤勉尽责，恪尽职守，认真履职的原则，对公司会计师事务所 2023 年度履行监督职责的情况汇报如下： 一、 2023 年年审会计师事务所基本情况 （一） 会计师事务所的基本情况 中汇会计师事务所（特殊普通合伙）（以下简称"中汇会计师事务所"、"中 汇"），于 2013 年 12 月转制为特殊普通合伙，管理总部设立于杭州，系原具有 证券、期货业务审计资格的会计师事务所之一，长期从事证券服务业务。截至 2023 年末，合伙人 103 人，注册会计师 701 人，签署过证券服务业务审计报告 的注册会计师 282 人。中汇会计师事务所在中国注册会计师协会发布的《2022 年度会计师事务所综合评价百家排名信息》中排名第十五位。 三、 审计委员会对会计师事务所的监督情况 2023 年度，审计委员会对会 ...

证券代码：300849 证券简称：锦盛新材 公告编号：2024-014 浙江锦盛新材料股份有限公司 关于公司修订、制定相关制度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易 所创业板股票上市规则》《上市公司独立董事管理办法》《上市公司监管指引第 3 号——上市公司现金分红》及《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》等相关法律法规及规范性文件的规定，结合浙江 锦盛新材料股份有限公司（以下简称"公司"）实际情况，为规范运作，进一步 完善公司治理体系，公司拟对相关制度进行修订、制定。本次修订、制定的制度 如下： | 序号 | 制度名称 | 类型 | 是否提交股东大会审议 | | --- | --- | --- | --- | | 1 | 《董事会议事规则》 | 修订 | 是 | | 2 | 《独立董事工作制度》 | 修订 | 是 | | 3 | 《董事会专门委员会议事规则》 | 修订 | 否 | | 4 | 《委托理财管理制度》 | 修订 | 否 | | ...

Revenue and Profitability - The company's revenue for Q1 2024 was ¥67,076,964.31, representing a 31.60% increase compared to ¥50,969,623.03 in the same period last year[4] - Net profit for Q1 2024 was a loss of ¥983,439.40, an improvement from a loss of ¥6,960,798.93 in Q1 2023[21] - The gross profit margin for Q1 2024 was 20.44%, significantly up from 7.07% in the same period last year, primarily due to increased business volume leading to lower unit costs[10] - Basic earnings per share for Q1 2024 were -¥0.01, an improvement from -¥0.05 in Q1 2023[21] Cash Flow and Financial Position - The net cash flow from operating activities was ¥3,158,906.59, down 18.65% from ¥3,883,323.67 in the previous year[10] - The company reported a significant increase in cash inflow from operating activities, totaling ¥82,574,734.16, compared to ¥60,668,324.48 in the previous year[23] - The net increase in cash and cash equivalents for Q1 2024 was 11,822,900.71 CNY, contrasting with a decrease of 8,675,025.47 CNY in Q1 2023[24] - Cash and cash equivalents at the end of Q1 2024 amounted to 84,263,239.05 CNY, a slight decrease from 86,218,580.66 CNY at the end of Q1 2023[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥802,497,517.27, a decrease of 5.85% from ¥852,355,845.49 at the end of the previous year[4] - Current assets decreased to CNY 353,057,927.12 from CNY 393,707,386.95, primarily due to a reduction in cash and cash equivalents[16] - Total liabilities decreased to CNY 182,079,311.14 from CNY 230,954,199.96, indicating a reduction of about 21%[17] - The company's total equity attributable to shareholders was ¥620,418,206.13, slightly down from ¥621,401,645.53 in the previous period[21] Expenses and Investments - Total operating costs amounted to ¥69,018,640.00, up 11.0% from ¥62,128,135.25 year-on-year[20] - Research and development expenses increased to ¥3,142,765.45, compared to ¥2,802,786.95 in the same quarter last year, reflecting a growth of 12.1%[20] - The company recorded a cash inflow of ¥50,000,000.00 from investment recovery, indicating active investment management[23] Shareholder Information - The total number of shareholders holding more than 5% of shares includes Ningbo Liyi Equity Investment Center with 16.75% and Shaoxing Jinsong Enterprise Management Consulting with 5.25%[14] Government Support - The company received government subsidies amounting to ¥755,675.62 during the reporting period[5] Credit and Impairment - The company experienced a significant increase in credit impairment losses, which rose by 285.74% to ¥401,588.49 due to an increase in accounts receivable[9] Accounting and Audit - The company has adopted new accounting standards starting from 2024, affecting the financial statements[25] - The company did not undergo an audit for the Q1 2024 report[25]